Characterization of extracellular vesicles derived from cortical bone stem cells compared with mesenchymal stem cells

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Extracellular vesicles (EVs) are promising for regenerative medicine, serving as alternatives to stem cells and drug delivery systems.
• EV properties vary based on their cell of origin, necessitating characterization for therapeutic use.
• Previous studies identified cellular differences between mouse cortical bone-derived stem cells (mCBSCs) and mouse mesenchymal stem cells (mMSCs).

Purpose of the Study:

• To characterize mouse cortical bone-derived stem cell-derived EVs (mCBSC-EVs) and compare their properties and biological actions with mouse mesenchymal stem cell-derived EVs (mMSC-EVs).
• To evaluate the potential of mCBSC-EVs in regenerative medicine applications.

Main Methods:

• Proteomic and glycomic analyses were performed on mCBSC-EVs and mMSC-EVs.
• Lectin microarrays were used to identify glycan differences.
• In vitro assays assessed the uptake and functional effects of EVs on mouse endothelial cells (mECs).

Main Results:

• Proteomic analysis revealed unique proteins in both mCBSC-EVs and mMSC-EVs.
• Glycomic analysis showed significant differences in glycan expression, including fucosylated glycans and sialic acid structures.
• mCBSC-EVs were preferentially taken up by mECs and induced greater upregulation of adhesion and inflammatory molecules compared to mMSC-EVs, while both elicited comparable tube-like structure formation.

Conclusions:

• mCBSC-EVs and mMSC-EVs exhibit distinct cargo contents and biological activities.
• mCBSC-EVs demonstrate superior properties, suggesting their potential as therapeutic agents.
• mCBSC-EVs may be beneficial for treating conditions like wound healing and angiogenesis in ischemic diseases.